Functional and Biochemical Rationales for the 24-Hour-Long Duration of Action of Olodaterol (Q34167323)

31 July 2017

title

Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol (English)

1 reference

31 July 2017

Functional and Biochemical Rationales for the 24-Hour-Long Duration of Action of Olodaterol (English)

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1124/JPET.111.179259

25 November 2024

Paola Casarosa

1 reference

31 July 2017

Ines Kollak

1 reference

31 July 2017

Tobias Kiechle

1 reference

31 July 2017

Angela Ostermann

1 reference

31 July 2017

Andreas Schnapp

1 reference

31 July 2017

Ralf Kiesling

1 reference

31 July 2017

Michael Pieper

1 reference

31 July 2017

Peter Sieger

1 reference

31 July 2017

Florian Gantner

1 reference

31 July 2017

language of work or name

English

0 references

publication date

28 February 2011

1 reference

full work available at URL

31 July 2017

https://syndication.highwire.org/content/doi/10.1124/jpet.111.179259

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1124/JPET.111.179259

Journal of Pharmacology and Experimental Therapeutics

25 November 2024

published in

1 reference

31 July 2017

volume

337

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

600-609

1 reference

Why are long-acting beta-adrenoceptor agonists long-acting?

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Salmeterol, a novel, long-acting β2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Overcoming barriers to nonadherence in asthma treatment

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

The global burden of asthma

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

CC and CX3C chemokines differentially interact with the N terminus of the human cytomegalovirus-encoded US28 receptor

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Novel long-acting bronchodilators for COPD and asthma

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Influence of beta 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells.

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Asthma and chronic obstructive pulmonary disease

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

The mode of action of nicotine and curari, determined by the form of the contraction curve and the method of temperature coefficients

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Heterotrimeric G protein signaling: role in asthma and allergic inflammation

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

The pharmacology of salmeterol

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Formoterol fumarate, a new beta 2-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Salmeterol multicentre asthma research trial (SMART): interim analysis shows increased risk of asthma related deaths.

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Structure of a nanobody-stabilized active state of the β(2) adrenoceptor

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

Beta-adrenoceptor agonists and asthma--100 years of development

25 November 2024

1 reference

https://api.crossref.org/works/10.1124/JPET.111.179259

25 November 2024

Identifiers

DOI

1 reference

31 July 2017

1 reference